Navigation Links
246 Study Participants Reported the Health Benefits of the TA-65 Telomerase Activator
Date:8/23/2013

ion included 246 participants from 11 countries who volunteered to fill out a confidential survey questionnaire that contained questions about the subjective changes noticed after starting to take the TA-65 supplement.

84 percent of respondents recognized the progress in immune function, 73 percent were complimented by friends and family on improvements in their appearance, while 82 percent of participants saw great improvement in mood and sense of general well-being.

These findings are consistent with previous studies. Furthermore, 73 percent of participants also noticed improvements in the quality of their skin, 74 percent had less frequent colds (a testament to the improved immune function), 74 percent noticed improved energy, and 61 percent greater exercise tolerance and endurance.

A high percentage of respondents noted improvements in other areas, including quality of sleep, hair, vision and sexual function, while they also experienced improved joint mobility, as well as a reduction in joint pain.

Moreover, to determine the benefits of regular intake, participants were divided into two groups: those who were taking TA-65 less than six months, and those who were taking it longer.

The results showed a significant improvement in participants taking the pills for more than six months. The percentage of those who recognized the progress in immune function increased to 93 percent (from 72 percent with less than six months users), 91 percent were complimented by friends and family on improvements in their appearance compared with 50 percent, 90 percent of participants saw great improvement in mood and sense of general well-being, a jump from 71 percent, and 82 percent of those surveyed noticed improvements in the quality of their skin as well from 61 percent. Accordingly, the percentage of those wh
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Single injection may revolutionize melanoma treatment, Moffitt study shows
2. Study helps explain increased melanoma risk in individuals with red hair
3. UCLA Nursing study suggests focus on lifestyle changes -- not weight loss -- is key to kids health
4. Study finds grandmothers who raise their grandkids struggle with depression
5. Study: Disease caused by repeat brain trauma in athletes may affect memory, mood, behavior
6. Case study collection diagnostic dilemmas hones physicians skills
7. Shocking New CDC Study Confirms U.S. Tick-Borne Disease Epidemic, Shows Lyme Disease Rates 10X Higher than Previously Reported
8. Penn Medicine study shows survivorship care plans empower cancer patients
9. UCLA study suggests iron is at core of Alzheimers disease
10. Brain cancer survival improved following FDA approval of bevacizumab, Mayo study finds
11. The concussed brain at work: fMRI study documents brain activation during concussion recovery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... (PRWEB) August 27, 2014 ... governance, and compliance software solutions for next-generation social ... Inc. magazine’s Inc. 500|5000, an exclusive ranking of ... consecutive year. AvePoint joins brands such as Alex ... 2014 edition. , This underscores continued growth ...
(Date:8/27/2014)... BambooIndustry.com is one of the most loved online bamboo product ... sale now. Recently, it has announced its new selection of ... BambooIndustry.com strives to offer one-stop shopping solutions for people who ... Now, it is providing big discounts for all the brand ... enjoy a discounted price (up to 30% off) before the ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 AttorneyOne.com, a ... all the latest information from the FDA on ... on August 1, that Organic Raw Carob Powder sold ... recalled due to possible contamination with Salmonella. ... with weakened immune systems. In healthy people it can ...
(Date:8/27/2014)... Crossing, PA (PRWEB) August 27, 2014 Time ... successfully launched its first-ever golf event! , With 80-degree ... for the Time To Play Golf (TTPGolf) Inaugural Outing. Around ... August 4th event, staged at the beautiful Heron Glen Golf ... with a bang and everyone seemed to be having a ...
(Date:8/27/2014)... OR (PRWEB) August 27, 2014 The ... improve quality of life and may eliminate the need ... controversy. During a recent AllMed webinar, Dr. Zanhua Yi, ... issues related to determining medical necessity of erythropoiesis-stimulating agents ... disease (CKD). , The U.S. Food and Drug Administration ...
Breaking Medicine News(10 mins):Health News:Inc. Magazine Names AvePoint to the Inc. 500|5000 List of Fastest Growing American Companies for the Fifth Consecutive Year 2Health News:Inc. Magazine Names AvePoint to the Inc. 500|5000 List of Fastest Growing American Companies for the Fifth Consecutive Year 3Health News:Brand New Bamboo Plywoods Now Offered At BambooIndustry.com 2Health News:Organic Raw Carob Powder by Sunburst SuperFoods Recalled: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Recap: Time To Play Golf Inaugural Golf Outing 2Health News:AllMed Webinar Helps Health Plans Determine Medical Necessity Of ESAs In The Treatment Of Chronic Kidney Disease 2Health News:AllMed Webinar Helps Health Plans Determine Medical Necessity Of ESAs In The Treatment Of Chronic Kidney Disease 3
... The Songs of Love ... uplifting, personalized songs for children and teens struggling with a life-threatening ... professionally produced with lyrics containing the child,s name and references to ... Songs are written and performed in the musical style that the ...
... improved hearing and alleviated other symptoms in patients with ... appear in the July 23 New England Journal ... researchers from Massachusetts General Hospital (MGH) report that bevacizumab ... of NF2 patients, the first reported successful NF2 treatment ...
... The world-wide explosion of overweight people has been called ... recognized. Could it really be an epidemic involving an ... increasing prevalence of overweight conditions in our society, investigators ... as a potential direct contributor to obesity. ...
... WASHINGTON, July 8 The results of a study published ... Journal (BMJ) support the findings of a white paper released ... (SCHS) regarding the potentially lifesaving qualities of cholesterol lowering drugs ... "In patients without established cardiovascular disease but with cardiovascular risk ...
... , TROIS-RIVIERES, Quebec, July 8 The Narconon drug rehab ... involved with drug related charges due to their addiction. ... a drug addiction, and just one day gets caught by ... a representative of Narconon Trois-Rivieres. "This is an all ...
... July 8 On the heels of a new campaign launched ... to unsightly "canckles," Dr. Marc Mittleman, founder and director of ... clubs and their members to focus on a real health issue ... in warm, moist environments like locker rooms, communal showers, pool and ...
Cached Medicine News:Health News:Donate Your Car to the Songs of Love Car Donation Program 2Health News:Anti-angiogenesis treatment improves hearing in some NF2 patients 2Health News:Anti-angiogenesis treatment improves hearing in some NF2 patients 3Health News:British Medical Journal Report Supports SCHS White Paper on Statins 2Health News:Drug Crimes in Canada Cause Continuing Problems for Small Communities 2Health News:While Health Clubs Say No to 'Canckles,' Leading Podiatrists Say No to Toenail Fungus 2Health News:While Health Clubs Say No to 'Canckles,' Leading Podiatrists Say No to Toenail Fungus 3
(Date:8/26/2014)... -- Based on its recent analysis of the breast imaging solutions ... North American Frost & Sullivan Award for Technology Innovation Leadership. ... solutions for the early detection of breast cancer. Over the ... solutions and has expanded its global reach to cover ... , Asia and Australia ...
(Date:8/26/2014)... 26, 2014 Novira Therapeutics, Inc., a privately ... of chronic hepatitis B virus (HBV) infection, today announced ... appointed the Chair of its Scientific Advisory Board (SAB). ... Senior Advisor to the Company.  "We ... Chair," said Christian Schade , Chief Executive Officer ...
(Date:8/26/2014)... 2014  Zimmer Holdings, Inc. (NYSE and SIX: ZMH), a ... of Directors has approved the payment of a quarterly cash ... The cash dividend of $0.22 per share will ... of record as of the close of business on September ... of the Board of Directors and may be adjusted as ...
Breaking Medicine Technology:Frost & Sullivan Applauds Volpara Solutions' Clear Vision in Identifying the Importance of Dose Tracking and Quantitative Analytics in the Early Detection of Breast Cancer 2Frost & Sullivan Applauds Volpara Solutions' Clear Vision in Identifying the Importance of Dose Tracking and Quantitative Analytics in the Early Detection of Breast Cancer 3Frost & Sullivan Applauds Volpara Solutions' Clear Vision in Identifying the Importance of Dose Tracking and Quantitative Analytics in the Early Detection of Breast Cancer 4Frost & Sullivan Applauds Volpara Solutions' Clear Vision in Identifying the Importance of Dose Tracking and Quantitative Analytics in the Early Detection of Breast Cancer 5Novira Therapeutics Announces Appointment of Roger J. Pomerantz, M.D., F.A.C.P., as Chair of Scientific Advisory Board 2Novira Therapeutics Announces Appointment of Roger J. Pomerantz, M.D., F.A.C.P., as Chair of Scientific Advisory Board 3Novira Therapeutics Announces Appointment of Roger J. Pomerantz, M.D., F.A.C.P., as Chair of Scientific Advisory Board 4
... Calif., Dec. 6 DURECT Corporation,(Nasdaq: ... Phase III trial for Remoxy,had successfully met ... by the U.S. Food and Drug Administration ... an investigational drug based on,DURECT,s patented ORADUR(TM) ...
... Colo., Dec. 5 Replidyne, Inc.,(Nasdaq: RDYN ) ... Collins will participate on the New and Powerful Anti-infectives,panel ... panel,discussion will take place at 11:00 am ET on ... New York City., A live audio webcast of ...
Cached Medicine Technology:Primary Endpoint of Pivotal Phase III Clinical Trial Achieved for Remoxy(TM) 2Primary Endpoint of Pivotal Phase III Clinical Trial Achieved for Remoxy(TM) 3Primary Endpoint of Pivotal Phase III Clinical Trial Achieved for Remoxy(TM) 4
30 cm - 11 3/4, packages 5 pcs....
Galt Skull Trephine with adjustable centering point and detachable cross-bar handle, 19.0 mm....
23 cm - 9, adult size, for skull thickness up to 12 mm....
Width 3 (76 mm), length 6 3/4 (171 mm). Pattie Tray attaches to long or short arm....
Medicine Products: